HDAC5 is involved in memory consolidation and targeting HDAC5 has been suggested to be avoided for the development of more selective HDAC inhibitors to treat Alzheimer’s disease [24]. Here, HDAC5 is linked to early-onset autosomal dominant Alzheimer disease.